Browse by Author "Calvo Martínez, Lourdes"

A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)

2015- Calvo Martínez, Lourdes

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

2012- Calvo Martínez, Lourdes

Association between bone turnover markers and skeletal-related events in patients with breast cancer and bone metastases on treatment with bisphosphonates: ZOMAR study results at nine months of follow-up

2011- Calvo Martínez, Lourdes

Association between bone turnover markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (zomar study)

2012- Calvo Martínez, Lourdes

Association Between Circulating Tumour Cells and Bone Turnover Markers in Patients With Breast Cancer and Bone Metastases on Treatment With Bisphosphonates (ZOMAR Study)

2011- Calvo Martínez, Lourdes

Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial

2013- Calvo Martínez, Lourdes

Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study)

2014- Calvo Martínez, Lourdes

Breast cancer management in the elderly

2014- Calvo Martínez, Lourdes; García Mata, Jesús; Cueva Bañuelos, Juan Fernando

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: Results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

2012- Calvo Martínez, Lourdes

Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer

2014- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Reboredo Lopez, Margarita; [et al.]

Circulating MicroRNAs: Molecular microsensors in gastrointestinal cancer

2012- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Figueroa Conde-Valvís, Angélica; [et al.]

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

2012- Valladares Ayerbes, Manuel; Reboredo Lopez, Margarita; Medina Villaamil, Vanessa; Iglesias Díaz, Pilar; Lorenzo Patiño, María José; [et al.]

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study

2022- Lope, V.; Guerrero-Zotano, A.; Ruiz-Moreno, E.; Bermejo, B.; Antolín Novoa, Silvia; [et al.]

Clinical implications of epithelial cell plasticity in cancer progression

2015- Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Figueroa Conde-Valvís, Angélica; Calvo Martínez, Lourdes; Carballo Castosa, Raquel; [et al.]

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: Results from the GEICAM 9906 trial

2014- Calvo Martínez, Lourdes

Defining breast cancer intrinsic subtypes by quantitative receptor expression

2015- Calvo Martínez, Lourdes

Development and validation of a sexual relations satisfaction scale in patients with breast cancer -

2019- R.G., Mancha; M., Munoz; L., De La Cruz-Merino; Calvo Martínez, Lourdes; J., Cruz; [et al.]

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

2015- Calvo Martínez, Lourdes

Evaluación de un programa de reconstrucción mamaria inmediata mediante expansión-prótesis en mujeres con cáncer de mama

2014- Acea Nebril, Benigno; Antolín Novoa, Silvia; Mosquera Oses, Joaquín José; Cereijo Garea, Carmen; Calvo Martínez, Lourdes; [et al.]

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

2013- Calvo Martínez, Lourdes

RUNA digital repository

Browse by Author "Calvo Martínez, Lourdes"

A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study) ﻿

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study ﻿

Association between bone turnover markers and skeletal-related events in patients with breast cancer and bone metastases on treatment with bisphosphonates: ZOMAR study results at nine months of follow-up ﻿

Association between bone turnover markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (zomar study) ﻿

Association Between Circulating Tumour Cells and Bone Turnover Markers in Patients With Breast Cancer and Bone Metastases on Treatment With Bisphosphonates (ZOMAR Study) ﻿

Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial ﻿

Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study) ﻿

Breast cancer management in the elderly ﻿

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: Results from the GEICAM/2006-03, a multicenter, randomized, phase-II study ﻿

Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer ﻿

Circulating MicroRNAs: Molecular microsensors in gastrointestinal cancer ﻿

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer ﻿

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study ﻿

Clinical implications of epithelial cell plasticity in cancer progression ﻿

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: Results from the GEICAM 9906 trial ﻿

Defining breast cancer intrinsic subtypes by quantitative receptor expression ﻿

Development and validation of a sexual relations satisfaction scale in patients with breast cancer - ﻿

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study ﻿

Evaluación de un programa de reconstrucción mamaria inmediata mediante expansión-prótesis en mujeres con cáncer de mama ﻿

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study ﻿

A phase I study of LDE225 in combination with docetaxel in patients with triple negative (TN) advanced breast cancer (ABC): GEICAM/2012-12 (EDALINE study)

A randomized phase II trial of platinum salts in basal-like breast cancer patients in the neoadjuvant setting. Results from the GEICAM/2006-03, multicenter study

Association between bone turnover markers and skeletal-related events in patients with breast cancer and bone metastases on treatment with bisphosphonates: ZOMAR study results at nine months of follow-up

Association between bone turnover markers in patients with breast cancer and bone metastases on treatment with bisphosphonates (zomar study)

Association Between Circulating Tumour Cells and Bone Turnover Markers in Patients With Breast Cancer and Bone Metastases on Treatment With Bisphosphonates (ZOMAR Study)

Biomarkers for predicting taxane efficacy in ER+/HER2-breast cancer patients: From in-vitro chemosensitivity screening to clinical validation in the GEICAM/ 9906 trial

Bone turnover markers as predictive indicators of outcome in patients with breast cancer and bone metastases treated with bisphosphonates: results from a 2-year multicentre observational study (ZOMAR study)

Breast cancer management in the elderly

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: Results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer

Circulating MicroRNAs: Molecular microsensors in gastrointestinal cancer

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study

Clinical implications of epithelial cell plasticity in cancer progression

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: Results from the GEICAM 9906 trial

Defining breast cancer intrinsic subtypes by quantitative receptor expression

Development and validation of a sexual relations satisfaction scale in patients with breast cancer -

Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study

Evaluación de un programa de reconstrucción mamaria inmediata mediante expansión-prótesis en mujeres con cáncer de mama

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study